Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

Antoine Vanier; Judith Fernandez; Sophie Kelley; Lise Alter; Patrick Semenzato; Corinne Alberti; Sylvie Chevret; Dominique Costagliola; Michel Cucherat; Bruno Falissard; François Gueyffier; Jérôme Lambert; Etienne Lengliné; Clara Locher; Florian Naudet; Raphael Porcher; Rodolphe Thiébaut; Muriel Vray; Sarah Zohar; Pierre Cochat; Dominique Le Guludec

doi:10.1136/bmjebm-2022-112091

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

PDF +
Supplementary
Material

EBM analysis

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

	Abstract	Full	Pdf
Feb 2023	2283	2291	1619
Total	2283	2291	1619

Main menu

Online download statistics by month:

Online download statistics by month: February 2023 to February 2023

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: February 2023 to February 2023

Read the full text or download the PDF:

Log in using your username and password